Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

December 15, 2016

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
Alopecia Areata
Interventions
DRUG

PF-06651600

200 mg QD during induction and 50 mg QD during Maintenance

DRUG

PF-06700841

60 mg QD during induction and 30 mg QD during maintenance

DRUG

Placebo

Placebo

Trial Locations (55)

2217

Dr. Glen and Partners Medical Imaging, Kogarah

St George Dermatology and Skin Cancer Centre, Kogarah

St. George Hearing and Balance Clinic, Kogarah

2220

Hearing Life, Hurstville

3002

Sinclair Dermatology, East Melbourne

3053

Skin & Cancer Foundation Inc., Carlton

3121

Bridge Road Imag ing, Richmond

Richmond Audiology, Richmond

4102

Veracity Clinical Research, Woolloongabba

4217

The Skin Centre, Benowa

10021

Weill Cornell Medicine, New York

10029

Icahn School of Medicine at Mount Sinai, New York

Mount Sinai Department of Otolaryngology, New York

10065

Rockefeller University Hospital, New York

14642

Investigational Drug Service, Rochester

University of Rochester Audiology, Rochester

University of Rochester Medical Center, Rochester

University of Rochester Radiology, Rochester

23502

Virginia Clinical Research, Inc., Norfolk

30263

MedaPhase Inc., Newnan

32073

Park Avenue Dermatology Administrative Annex, Orange Park

Park Avenue Dermatology, Orange Park

33609

Edward B. Kampsen, MD, Tampa

Olympian Clinical Research, Tampa

Rose Radiology, Tampa

33624

Forward Clinical Trials, Inc, Tampa

35233

University of Alabama at Birmingham, Dermatology at the Whitaker Clinic, Birmingham

University of Alabama at Birmingham, The Kirklin Clinic, Birmingham

46256

Dawes Fretzin Clinical Research Group, LLC, Indianapolis

Dawes Fretzin Dermatology Group, LLC, Indianapolis

57702

Health Concepts, Rapid City

60077

NorthShore University HealthSystem Dermatology Clinical Trials Unit, Skokie

74136

Vital Prospects Clinical Research Institute, P.C., Tulsa

80045

University of Colorado Hospital Clinical and Translational Research Center, Inpatient Unit, Aurora

University of Colorado Hospital Clinical and Translational Research Center, Outpatient Clinic, Aurora

University of Colorado Hospital, Anschutz Cancer Pavilion, Aurora

84107

University of Utah MidValley Dermatology, Murray

84132

University of Utah Medical Center, Salt Lake City

90404

Clinical Science Institute, Santa Monica

Office of F. Monte Purcelli, Santa Monica

Tower Saint John's Imaging, Santa Monica

92701

Southern California Dermatology, Inc., Santa Ana

06510

Yale School of Medicine, New Haven

06511

Investigational Drug Services, New Haven

06519

Church Street Research Unit, New Haven

Yale Hearing and Balance Center, New Haven

Yale New Haven Hospital, New Haven

02111

Tufts Medical Center, Boston

02114

Massachusetts General Hospital Clinical Unit for Research Trials in Skin (CURTIS), Boston

R3M 3Z4

Wiseman Dermatology Research Inc., Winnipeg

L3P 1X2

Lynderm Research Inc., Markham

L6J 7W5

Research by ICLS, Oakville

K9J 5K2

SKiN Centre for Dermatology, Peterborough

L4B 1A5

The Centre for Dermatology, Richmond Hill

L4C 9M7

York Dermatology Center, Richmond Hill

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02974868 - Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata | Biotech Hunter | Biotech Hunter